Access to AI in Medical Education: Innovating and Inclusive

By Sumona Bose

December 15, 2023

Introduction

Artificial intelligence (AI) has become an innovative force in various industries, and its potential in healthcare is no exception. Access to AI in Medical Education is an important area of exploration. In the field of medical education, AI is being explored for its applications in training, learning, simulation, curriculum development, and assessment tools. This article aims to highlight the inclusive nature of AI in medical education, showcasing its potential to transfigure the way we teach and learn.

Expanding Possibilities

AI has the ability to enhance medical education in numerous ways. For instance, machine-learning bots can now generate content such as Wikipedia articles, assignments, novels, and book chapters. This raises questions about the suitability of current policies and regulations, copyright concerns, and the need for alternative assessment methods to adapt to these advancements.

Defining AI in Medical Education

Artificial Intelligence (AI) is the science and engineering of creating intelligent machines and smart computer programs. It encompasses a wide range of applications, from general research on learning and perception to specialized tasks like diagnosing diseases and driving cars. In the context of medical education, AI can be utilized to improve various specialties, including medical imaging, cancer histopathology, cardiology, and pediatric ophthalmology.

Exploring AI in Medical Education

The applications of AI in medical education are vast and promising. For example, AI can be used in surgical education and training, reshaping the teaching of radiology, improving AI literacy in oral and dental education, and assessing surgical expertise. The future physician will need to effectively incorporate AI in patient care tasks, collaborate with patients using AI for self-management, and utilize AI to improve healthcare operations and reduce errors.

Addressing Key Questions

The integration of AI in medical education raises important questions that need to be addressed. How will AI-driven changes impact undergraduate and postgraduate medical curricula? How can AI be used to empower disadvantaged groups, including ethnic and religious minorities? How can AI preserve the capacity of physicians to focus on tasks that require human expertise while improving accessibility to healthcare for vulnerable populations? What role should policymakers, tech companies, research institutes, and society play in adapting medical education to the introduction of AI? Additionally, what alternative assessment methods can replace traditional question formats?

Conclusion

AI has the potential to reshape medical education by providing innovative and inclusive solutions. By embracing AI in medical curricula, teaching and learning methods, and student assessment, we can prepare future physicians to effectively utilize AI in patient care.

 

Reference url

Recent Posts

Advancing B7-H3 Targeted Therapy for Relapsed Extensive-Stage Small Cell Lung Cancer

By HEOR Staff Writer

April 15, 2026

The FDA’s Priority Review of ifinatamab deruxtecan was recently announced, a potential first-in-class B7-H3 targeted therapy. The Biologics License Application for ifinatamab deruxtecan (I-DXd), a B7-H3 directed DXd antibody drug conjugate (ADC), has been accepted with a Prescription Drug User Fe...
Advancing Inclusive Healthcare Strategies Through Social Impact and Sustainability
In this update we examine how Novartis is embedding inclusive healthcare strategies into its core business by launching ambitious long-term Social Impact and Sustainability (SI&S) targets that reach to 2040. These targets integrate innovation, access to medicines, global health, environmental...
Advancing Access: Generic Dapagliflozin Approval Enhanced for Type 2 Diabetes Treatment

By João L. Carapinha

April 14, 2026

The U.S. Food and Drug Administration has issued the generic dapagliflozin approval, clearing the first generic versions of FARXIGA (dapagliflozin) tablets. This decision significantly improves affordability and access to an important SGLT2 inhibitor for adults with type 2 diabetes. ...